Shenzhen Chipscreen Biosciences Co (SHSE:688321) Total Receivables: ¥317 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688321 Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
73 GF Score
Price ¥25.95
GF Value ¥38.42
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Shenzhen Chipscreen Biosciences Co Total Receivables?

Shenzhen Chipscreen Biosciences Co SHSE:688321 -5.33% 73 Total Receivables is ¥317 Mil as of Mar. 2026. GuruFocus rates SHSE:688321 with a GF Score™ of 73/100 and a GF Value™ of ¥38.42 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Shenzhen Chipscreen Biosciences Co's Total Receivables for the quarter that ended in Mar. 2026 was ¥317 Mil.

Shenzhen Chipscreen Biosciences Co Total Receivables Related Terms

Shenzhen Chipscreen Biosciences Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Shenzhen Chipscreen Biosciences Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Chipscreen Biosciences Co Total Receivables Chart

Shenzhen Chipscreen Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 122.93 168.24 221.53 178.39 307.30

Shenzhen Chipscreen Biosciences Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 148.92 215.94 297.41 307.30 317.14
SHSE:688321
73GF Score
Shenzhen Chipscreen Biosciences Co Ltd SHSE:688321
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Chipscreen Biosciences Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ¥317 Mil mean?
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a Total Receivables of ¥317 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors.
Is Shenzhen Chipscreen Biosciences Co's Total Receivables too high?
Shenzhen Chipscreen Biosciences Co's current Total Receivables is ¥317 Mil. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's Total Receivables compare to ZTS?
Shenzhen Chipscreen Biosciences Co's Total Receivables of ¥317 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. Shenzhen Chipscreen Biosciences Co's current Total Receivables is ¥317 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥38.42, compared to a current price of ¥25.95 — trading 32.5% below its estimated fair value. The current Total Receivables is ¥317 Mil. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current Total Receivables is ¥317 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued. The current stock price of ¥25.95 is trading 32.5% below its estimated GF Value™ of ¥38.42. GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Significantly Undervalued.

Key valuation signals for SHSE:688321:

  • Total Receivables: ¥317 Mil
  • GF Value™: ¥38.42 vs. price of ¥25.95 (32.5% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen Chipscreen Biosciences Co Business Description

Address No. 10, Gaoxin Zhongyi, Room 601-606, Building 2, Shenzhen Biological Incubation Base, Gaoxin Zhongyi, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.
73GF Score

Get the complete analysis for SHSE:688321

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.95
Price
¥38.42
GF Value